221 related articles for article (PubMed ID: 12746221)
1. Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin.
Goralski KB; Hartmann G; Piquette-Miller M; Renton KW
Br J Pharmacol; 2003 May; 139(1):35-48. PubMed ID: 12746221
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide treatment downregulates the expression of the pregnane X receptor, cyp3a11 and mdr1a genes in mouse placenta.
Chen YH; Wang JP; Wang H; Sun MF; Wei LZ; Wei W; Xu DX
Toxicology; 2005 Aug; 211(3):242-52. PubMed ID: 15869837
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats.
Cherrington NJ; Slitt AL; Li N; Klaassen CD
Drug Metab Dispos; 2004 Jul; 32(7):734-41. PubMed ID: 15205389
[TBL] [Abstract][Full Text] [Related]
4. Brain cyclosporin A levels are determined by ontogenic regulation of mdr1a expression.
Goralski KB; Acott PD; Fraser AD; Worth D; Sinal CJ
Drug Metab Dispos; 2006 Feb; 34(2):288-95. PubMed ID: 16303871
[TBL] [Abstract][Full Text] [Related]
5. Altered drug disposition of the platelet activating factor antagonist apafant in mdr1a knockout mice.
Leusch A; Volz A; Müller G; Wagner A; Sauer A; Greischel A; Roth W
Eur J Pharm Sci; 2002 Aug; 16(3):119-28. PubMed ID: 12128165
[TBL] [Abstract][Full Text] [Related]
6. Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats.
Kalitsky-Szirtes J; Shayeganpour A; Brocks DR; Piquette-Miller M
Drug Metab Dispos; 2004 Jan; 32(1):20-7. PubMed ID: 14709616
[TBL] [Abstract][Full Text] [Related]
7. Morphological and functional changes in p-glycoprotein during dexamethasone-induced hepatomegaly.
Micuda S; Fuksa L; Mundlova L; Osterreicher J; Mokry J; Cermanova J; Brcakova E; Staud F; Pokorna P; Martinkova J
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):296-303. PubMed ID: 17324141
[TBL] [Abstract][Full Text] [Related]
8. Selective and persistent upregulation of mdr1b mRNA and P-glycoprotein in the parahippocampal cortex of chronic epileptic rats.
van Vliet E; Aronica E; Redeker S; Marchi N; Rizzi M; Vezzani A; Gorter J
Epilepsy Res; 2004; 60(2-3):203-13. PubMed ID: 15380564
[TBL] [Abstract][Full Text] [Related]
9. Sequence-specific suppression of mdr1a/1b expression in mice via RNA interference.
Matsui Y; Kobayashi N; Nishikawa M; Takakura Y
Pharm Res; 2005 Dec; 22(12):2091-8. PubMed ID: 16184445
[TBL] [Abstract][Full Text] [Related]
10. Physiologically based pharmacokinetics of digoxin in mdr1a knockout mice.
Kawahara M; Sakata A; Miyashita T; Tamai I; Tsuji A
J Pharm Sci; 1999 Dec; 88(12):1281-7. PubMed ID: 10585223
[TBL] [Abstract][Full Text] [Related]
11. Lack of difference in pulmonary absorption of digoxin, a P-glycoprotein substrate, in mdr1a-deficient and mdr1a-competent mice.
Manford F; Riffo-Vasquez Y; Spina D; Page CP; Hutt AJ; Moore V; Johansson F; Forbes B
J Pharm Pharmacol; 2008 Oct; 60(10):1305-10. PubMed ID: 18812023
[TBL] [Abstract][Full Text] [Related]
12. Detection of P-glycoprotein activity in endotoxemic rats by 99mTc-sestamibi imaging.
Wang JH; Scollard DA; Teng S; Reilly RM; Piquette-Miller M
J Nucl Med; 2005 Sep; 46(9):1537-45. PubMed ID: 16157538
[TBL] [Abstract][Full Text] [Related]
13. Resolution of P-glycoprotein and non-P-glycoprotein effects on drug permeability using intestinal tissues from mdr1a (-/-) mice.
Stephens RH; O'Neill CA; Bennett J; Humphrey M; Henry B; Rowland M; Warhurst G
Br J Pharmacol; 2002 Apr; 135(8):2038-46. PubMed ID: 11959808
[TBL] [Abstract][Full Text] [Related]
14. Inflammation and interleukin-6 mediate reductions in the hepatic expression and transcription of the mdr1a and mdr1b Genes.
Sukhai M; Yong A; Kalitsky J; Piquette-Miller M
Mol Cell Biol Res Commun; 2000 Oct; 4(4):248-56. PubMed ID: 11409920
[TBL] [Abstract][Full Text] [Related]
15. Distinct alterations in ATP-binding cassette transporter expression in liver, kidney, small intestine, and brain in adjuvant-induced arthritic rats.
Kawase A; Norikane S; Okada A; Adachi M; Kato Y; Iwaki M
J Pharm Sci; 2014 Aug; 103(8):2556-64. PubMed ID: 24912442
[TBL] [Abstract][Full Text] [Related]
16. Effect of organophosphate pesticide diazinon on expression and activity of intestinal P-glycoprotein.
Lecoeur S; Videmann B; Mazallon M
Toxicol Lett; 2006 Mar; 161(3):200-9. PubMed ID: 16221533
[TBL] [Abstract][Full Text] [Related]
17. Region-dependent modulation of intestinal permeability by drug efflux transporters: in vitro studies in mdr1a(-/-) mouse intestine.
Stephens RH; Tanianis-Hughes J; Higgs NB; Humphrey M; Warhurst G
J Pharmacol Exp Ther; 2002 Dec; 303(3):1095-101. PubMed ID: 12438532
[TBL] [Abstract][Full Text] [Related]
18. Brain penetration of WEB 2086 (Apafant) and dantrolene in Mdr1a (P-glycoprotein) and Bcrp knockout rats.
Fuchs H; Kishimoto W; Gansser D; Tanswell P; Ishiguro N
Drug Metab Dispos; 2014 Oct; 42(10):1761-5. PubMed ID: 25053619
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan.
de Vries NA; Zhao J; Kroon E; Buckle T; Beijnen JH; van Tellingen O
Clin Cancer Res; 2007 Nov; 13(21):6440-9. PubMed ID: 17975156
[TBL] [Abstract][Full Text] [Related]
20. Characterization of SAGE Mdr1a (P-gp), Bcrp, and Mrp2 knockout rats using loperamide, paclitaxel, sulfasalazine, and carboxydichlorofluorescein pharmacokinetics.
Zamek-Gliszczynski MJ; Bedwell DW; Bao JQ; Higgins JW
Drug Metab Dispos; 2012 Sep; 40(9):1825-33. PubMed ID: 22711747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
